Bioharvest Sciences Inc.’s Growth Strategy Progress Update #3 Live Video Conference November 19, 2020 @ 2:00pm EST

Vancouver, BC / November 12, 2020, / BioHarvest Sciences Inc. (“BioHarvest” or the “Company”) (CSE: BHSC) invites its Shareholders and the General Public to join a Live Video Conference (“Webinar”) on Thursday, November 19, 2020, at 2:00 PM Eastern Standard Time. Ilan Sobel, CEO of BHSC, will host the event and provide significant progress updates on its previously announced Growth Strategy, shared publicly in early August and September. The CEO will be available for a question and answer session following the presentation. 

“I have committed to BHSC’s Shareholders that our team will work relentlessly to achieve our growth strategy. Thursday, November 19, I will share with our shareholders and the general public, meaningful scalable progress made since our last conference call in mid-September. The Company achieved several milestones over the past 8 weeks, specifically concerning the building of Best in Class B2C Capabilities to market our flagship product VINIA®, the application of VINIA® to relevant adjacent food categories and; the progressive composition of a world-class dream team to navigate and seize the breadth of opportunities available to BioHarvest. We are taking pride in our Company being slowly but surely noticed in the health and wellness industry.” Commented Ilan Sobel.

Click the following link to register: BHSC’s Shareholders Update, Nov 19, 2020 @ 2:00PM PST

The company’s email database will receive an invitation to register for the conference call, and all interested investors are welcomed to contact for further information.

About BioHarvest Sciences Inc.

Based in Vancouver BC, BioHarvest Sciences Inc. is the developer and exclusive owner of the proprietary and patent-protected BioFarming technology. It is the first and only industrial-scale plant cell technology capable of producing the active plant ingredients without the necessity to grow the plant itself. The Company’s technology is non-GMO and has already been validated by VINIA®, the red grapes cells functional food/dietary supplement produced and sold by BioHarvest Sciences Inc. The Company plans to generate significant revenue within the global nutraceutical ingredients and dietary supplements market with VINIA® and other Super Fruit Nutraceutical products. Further, by adapting this technology to the Cannabis plant, and building adequate production capacity, BioHarvest Sciences Inc.’s objective is to become a leading supplier of Cannabis for both medicinal and legal recreational purposes. Visit:

BioHarvest Sciences Inc.
Ilan Sobel, Chief Executive Officer

For further information, please contact:

Dave Ryan, VP Investor Relations & Director
Phone: 1 (604) 622-1186


Forward-Looking Statements 

Information set forth in this news release includes forward-looking statements that are based on management’s current estimates, beliefs, intentions, and expectations, and are subject to a number of risks and uncertainties that could cause actual results to differ materially from those described in the forward-looking statements. There is no assurance that strong sales metrics experienced to date will result in future demand or that proposed additional marketing expenditures will result in increased sales. Markets for nutraceuticals are unpredictable and subject to changes in consumer tastes and trends as well as economic factors beyond our control.  Delays and cost overruns may result in delays achieving our objectives obtaining market acceptance, and regulatory approvals for geographic expansion is subject to risk and cannot be guaranteed. There is no assurance that the Company sales revenue for 2022 will reach USD 5 to 7 million and there is no assurance that the Company cash flow breaking point will be achieved in 2023. There is no assurance of commercial availability of our Cannabis product in 2022 or that the Company achieves the conversion of the two tons VINIA® facility to Cannabis production in 2022. These things are subject to construction and approval delays and uncertainties that may be beyond the control of BioHarvest. Projected sales of Cannabis will require the Company to obtain production and/or export licensing which cannot be assured.

All forward-looking statements are inherently uncertain and actual results may be affected by a number of material factors beyond our control. Readers should not place undue reliance on forward-looking statements. BHSC does not intend to update forward-looking statement disclosures other than through our regular management discussion and analysis disclosures. 

Readers are cautioned that revenue alone do not give an accurate picture of the financial position of the Company and should be read in the context of the Company’s annual and quarterly financial statements.

Neither the Canadian Securities Exchange nor its Regulation Services Provider accept responsibility for the adequacy or accuracy of this release.